August 25, 2026 10:28 pm (IST)
Follow us:
Two Aurobindo Pharma products receive USFDA approval
Hyderabad/Mumbai, Apr 1 (IBNS) Aurobindo Pharma Limited announced on Friday that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Valganciclovir Tablets USP, 450 mg; and Vancomycin Hydrochloride for Injection USP, 500 mg/vial and 1 g/vial.
The company said that the Valganciclovir Tablet is to be launched in Q1 FY16-17 and the Vancomycin Hydrochloride for Injection in the later part of the same fiscal year.
Valganciclovir tablets is an anti-viral used in the treatment of Cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome and prevention of CMV disease in kidney, heart or kidney-pancreas transplant patients.
The approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Valcyte of Hoffman-La Roche Inc.
The approved product has an estimated market size of US$ 391 million for the12 months ending February 2016 according to IMS.
Vancomycin Hydrochloride for Injection is an antibiotic used in the treatment of severe infections caused by susceptible strains of methicillin-resistant (Beta-lactam resistant) staphylococci and others. The approved product has an estimated market size of US$ 94 million for the twelve months ending January 2016 according
to IMS.
The approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Vancomycin® Hydrochloride for Injection USP, 500 mg/vial and 1 g/vial, of Fresenius Kabi USA, LLC.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
RBI’s big forex boost: Banks mobilise $73 billion in just 11 weeks
Tue, Aug 25 2026
Tata Sierra.ev gets 5G superpowers as Tata Motors bets big on software-defined cars
Tue, Aug 25 2026
Bajaj Life Insurance launches ‘BSE 500 Momentum Value 50 Index Fund’ for ULIP customers. How to avail it?
Tue, Aug 25 2026
8 in 10 Digital Marketing Jobs in Mumbai Don't Ask for an MBA, Finds IIDE Review of 500 Job Descriptions
Tue, Aug 25 2026
How a minor bank account helps build savings habits early
Tue, Aug 25 2026
Sensex, Nifty slip in morning trade as metal stocks retreat; Shankesh Jewellers, Sunshine Pictures debut higher
Tue, Aug 25 2026
TCS, Porsche join forces in major AI move to transform mobility
Tue, Aug 25 2026